Tag: 5635(c)(4)

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

February 07, 2025 16:30 ET  | Source: ORIC Pharmaceuticals SOUTH SAN FRANCISCO,…

GlobeNews Wire GlobeNews Wire

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 07, 2025 16:30 ET  | Source: Fulcrum Therapeutics, Inc. CAMBRIDGE, Mass.,…

GlobeNews Wire GlobeNews Wire

Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 07, 2025 16:05 ET  | Source: Mersana Therapeutics, Inc. CAMBRIDGE, Mass.,…

GlobeNews Wire GlobeNews Wire

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 07, 2025 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, the…

GlobeNews Wire GlobeNews Wire

Replimune Announces Inducement Grants Under NasdaqListing Rule 5635(c)(4)

February 07, 2025 16:01 ET  | Source: Replimune Group Inc WOBURN, Mass.,…

GlobeNews Wire GlobeNews Wire

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq:…

GlobeNews Wire GlobeNews Wire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 24, 2025 16:05 ET  | Source: TELA Bio, Inc. MALVERN, Pa.,…

GlobeNews Wire GlobeNews Wire

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 24, 2025 16:01 ET  | Source: Chimerix, Inc. DURHAM, N.C., Jan.…

GlobeNews Wire GlobeNews Wire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 24, 2025 16:05 ET  | Source: TELA Bio, Inc. MALVERN, Pa.,…

GlobeNews Wire GlobeNews Wire

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 24, 2025 16:01 ET  | Source: Chimerix, Inc. DURHAM, N.C., Jan.…

GlobeNews Wire GlobeNews Wire